The WACC of Newbury Pharmaceuticals AB (NEWBRY.ST) is 5.0%.
| Range | Selected | |
| Cost of equity | 4.10% - 6.10% | 5.10% |
| Tax rate | 20.60% - 20.90% | 20.75% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 4.1% - 5.8% | 5.0% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.32 | 0.43 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 4.10% | 6.10% |
| Tax rate | 20.60% | 20.90% |
| Debt/Equity ratio | 0.17 | 0.17 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 4.1% | 5.8% |
| Selected WACC | 5.0% | |